NPI: 1730141896 · PHILADELPHIA, PA 19142 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,441 | $20K |
| 2020 | 5,542 | $302K |
| 2021 | 15,158 | $1.11M |
| 2022 | 7,577 | $867K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,367 | 2,135 | $2.28M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,157 | 540 | $20K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 395 | 137 | $912.82 |
| G0008 | Administration of influenza virus vaccine | 43 | 43 | $182.56 |
| 83970 | 644 | 483 | $0.00 | |
| 83540 | 223 | 217 | $0.00 | |
| 85048 | 393 | 371 | $0.00 | |
| 85041 | 393 | 371 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 1,197 | 299 | $0.00 |
| 82108 | 84 | 84 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 184 | 17 | $0.00 |
| A4657 | Syringe, with or without needle, each | 2,879 | 1,004 | $0.00 |
| 83550 | 223 | 217 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,132 | 357 | $0.00 |
| 82728 | 207 | 202 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 197 | 154 | $0.00 |